VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $27 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $27 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $74 | $50 | $43 | $16 |
| G&A Expenses | $34 | $36 | $14 | $8 |
| SG&A Expenses | $34 | $36 | $14 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $0 | $0 |
| Operating Expenses | $108 | $87 | $57 | $24 |
| Operating Income | -$81 | -$87 | -$57 | -$24 |
| % Margin | -294.5% | – | – | – |
| Other Income/Exp. Net | -$13 | -$0 | -$3 | $1 |
| Pre-Tax Income | -$94 | -$87 | -$60 | -$23 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | -$94 | -$87 | -$60 | -$24 |
| % Margin | -342.8% | – | – | – |
| EPS | -2.12 | -3.23 | -2.4 | -1.01 |
| % Growth | 34.4% | -34.6% | -137.6% | – |
| EPS Diluted | -2.12 | -3.23 | -2.4 | -1.01 |
| Weighted Avg Shares Out | 44 | 27 | 25 | 23 |
| Weighted Avg Shares Out Dil | 44 | 27 | 25 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $3 | $0 | $1 | $0 |
| Depreciation & Amortization | $1 | $0 | -$0 | $0 |
| EBITDA | -$80 | -$86 | -$58 | -$23 |
| % Margin | -292% | – | – | – |